Medtronic’s Symplicity Spyral RDN catheter secures CMS approval for boosted Medicare access
The US Centers for Medicare & Medicaid Services (CMS) has granted Medtronic plc, a global healthcare technology leader, transitional pass-through (TPT) payment status for its Symplicity Spyral renal denervation (RDN) catheter. This recognition, under the Medicare Hospital Outpatient Prospective Payment System, is set to be effective from January 1, 2025, for up to three years, […]